Our technologies can help you evaluate cellular permeability and affinity for target proteins and E3 ligases, which is fundamental to the successful development of degrader compounds.

  • NanoBRET® Target Engagement Assays measure protein-small molecule interactions in live cells
  • Lumit® Immunossays provide a high-throughput biochemical method to measure interactions in solution

Learn how to assess compound cell permeability and affinity to E3 ligases using NanoBRET® Target Engagement Assays.

Download Poster
Watch this video that introduces NanoBRET® Technology

How Do You Measure Cellular Permeability and Target Affinity in Live Cells?

Measure Cellular Interactions in Live Cells with NanoBRET® Target Engagement Assays

When developing degrader compounds, it is important to assess their cellular permeability and affinity for target proteins and E3 ligases. NanoBRET® Target Engagement (TE) technology measures protein-small molecule binding interactions in live cells, providing quantitative data on compound permeability, target affinity and residence time. We provide assays available for multiple target classes important in drug discovery, including kinases, histone deacetylases (HDAC), bromodomains and E3 ligases.

The NanoBRET® TE Intracellular E3 Ligase Assays allow live cell measurement of degrader compound affinity for E3 ubiquitin ligase proteins, Cereblon (CRBN) or von Hippel-Lindau disease tumor suppressor (VHL). The assay can be performed in live or permeabilized cells, which allows the user to assess both compound affinity for the E3 ligase and compound permeability in the same system.

View NanoBRET TE E3 Ligase Assays (CRBN, VHL)

Interested in NanoBRET® TE Assays for other E3 ligase, including cIAP1, cIAP2, XIAP and MDM2?

Contact Us
target engagement assay principle

 

Principle of the NanoBRET® Target Engagement

Measuring Cellular Affinity

BRD4 NanoBRET TE live cells
CRBN NanoBRET TE live and permeabilized cells

Measuring cellular affinity of BET degraders targeting BRD4 using the NanoBRET® TE Assay. Comparison of cellular binding affinity for two related PROTACs that target BRD4 (left panel) using a BRD4 NanoBRET® TE Assay. Degrader affinity for the E3 ligase CRBN was compared in live and permeabilized cells using a NanoBRET® TE CRBN Assay to assess contribution of compound permeability to measured binding affinity (right panel). The study revealed that dBET6 is more permeable than dBET1 and dBET6 has slightly higher affinity for CRBN compared to dBET1.

Quantifying Intracellular Availability

compound-permeability-figure
NanoBRET® TE technology allows determination of compound intracellular availability from the observed potency shift. Moreover, normalizing this relative shift in binding potency can be used to quantitatively assess relative intracellular availability of different compounds compared to a control. Download poster to see more data.

How Do You Biochemically Measure Target Affinity? 

Measure Protein-Small Molecule Interaction with Lumit® Immunoassays

Lumit® Immunoassays provide a biochemical method to monitor binary interactions between small molecules and target proteins. These assays use streptavidin and antibodies that recognize commonly used protein tags coupled with NanoLuc® Technology. The simple add-and- read protocol make them suitable for multiplexing and high- throughput screens.

Download Poster to See Data

Measuring Molecular Glue Interactions

Molecular glue interactions with Cereblon complex

Schematic overview of using Lumit® Immunoassays to measure interactions between molecular glues and cereblon complex.

cereblon-thalidomide tracer complex formation

Molecular glue interactions with cereblon complex. To determine the relative affinities of molecular glues, we titrated them into a cereblon-thalidomide tracer complex. As the tracer is competed off, the luminescent signal decreases. Relative IC50 values correlate to target engagement assays in lysed cells. Download poster to see more data or contact us for more information.

Need help with Assessing Cellular Permeability?

Learn more about our targeted protein degradation services.